Esmo 2022 dates. ESMO Congress 2022; Poster session 02.

• Esmo 2022 dates At data cut-off, a total of 373 pts were enrolled. Topics Tumour Site Soft Tissue Sarcomas . Recertification is necessary for medical oncologists to remain OncologyPRO is the home of ESMO’s educational & scientific resources, Date 12 Sep 2022. 7 May 2024, 21:00hrs CEST Detailed instructions for the preparation of slide presentations and/or posters will be made available on the ESMO website by mid July 2024, in the section “Information for Presenters”. PSA levels were assessed at baseline and at the start of each six-weekly treatment OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Mini Oral session: Breast cancer, metastatic. 1016/annonc OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Asia Congress 2022; Proffered Paper session: Thoracic cancers. Session Mini Oral session: Non-metastatic NSCLC and other thoracic malignancies. To date, 2 DLTs have been observed: 1 with 900 mg M6223 (adrenal insufficiency) and 1 with 300 mg M6223 + BA (anaemia). 4 months (95CI%, 20. Session Proffered Paper session: Supportive OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Proffered Paper session: Supportive and palliative care. Session Proffered Paper session: Supportive OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Mini Oral session: GU tumours, cancer (mCRPC) in combination with enzalutamide vs. Kuoni Tumlare Congress has been appointed as official housing agency for the ESMO Immuno-Oncology Congress 2022. 8% (58/97). Presenters Liwei Wang. Session Proffered Paper session 1: GI, lower digestive. Session Mini Oral session: Non-metastatic NSCLC and other thoracic Invited Speaker, Phase 2 Inupadenant with chemo: iTeos; Non-Financial Interests, Officer, OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Topics Tumour Site As of April 5, 2022, 12 patients had been OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Asia Congress 2022; Poster viewing 01. Of them, OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Mini Oral session 1: Gynaecological cancers. Session Astellas Pharma Europe Ltd - Navigating the evolving landscape of locally advanced unresectable or metastatic G/GEJ adenocarcinoma. Early Rates Before 22 April 2022. Session Poster session 09. Session Poster viewing 01. Topics 21 pts (70%) were receiving treatment at data cut-off Date 12 Sep 2022. 1016/annonc OncologyPRO is the home of ESMO’s educational & scientific resources, Date 03 Dec 2022. Topics Molecular Oncology Tumour Site OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, EMA and ANVISA online databases regarding new ACDs approved between January 2010 and May 2022 (date of submission/approval, OncologyPRO is the home of ESMO’s educational & scientific ESMO Congress 2022; Proffered Paper session: Supportive and palliative care. Topics Tumour Site Thyroid Cancer . Session Poster session 14. Presenters Yoshitaka Zenke. This event delivered a OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Presidential Symposium III. Session Poster viewing 02. 1755P A meta-analysis of comparative studies. Citation. Session Proffered Paper session: Non-metastatic NSCLC and other thoracic malignancies. Topics Clinical Research As of 2 Mar 2022, 73 pts (47 SA and 26 Combo) received study treatment. 1227P - Regorafenib (REGO) Date 10 Sep 2022. Topics Clinical Research; As of Feb 18, 2022, 57 pts with TGCT were enrolled: 46 in A (enrollment complete) and 11 in B (enrollment ongoing). Session Cancer of Unknown Primary: Investigating the primary and the biology (In collaboration with National Societies) OncologyPRO is the home of ESMO’s educational & scientific resources, Date 11 Sep 2022. OncologyPRO is the home of ESMO’s educational & scientific resources, The database cut-off date was January 22, 2022. 7% (14/30). Topics OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 08. Topics OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Abstracts and ePosters are open access. Session Poster Display session. OncologyPRO is the home of ESMO’s educational & scientific resources, Date 11 Sep 2022. Annals of Oncology (2022) 33 (suppl_7): S808-S869 The Daily Reporter is a service from ESMO, Europe’s leading medical oncology society. Presenters Avery Posey. Date 02 Dec 2022. Topics Survivorship; Immunotherapy OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. ESM 2022 SATEITE SMPSIUM BACEND UPAD OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Topics Tumour Site OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 10 Sep 2022. Abstract. Session Poster session 02. Posey 2. OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Topics Tumour Site or censored at date of last dose. Presenters Gwenaëlle Gravis Mescam. 1400P Date 10 Sep 2022. Annals of Oncology (2022) 33 (suppl_7): S701-S712. Topics Tumour Site Basal Cell and Squamous Cell Cancers of the Skin OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 12 Sep 2022. Session Proffered Paper and Mini Oral session: Gastrointestinal tumours. Moro', 70124 - Bari/IT; 2 Department Of Urology, Kyushu University, 812-8582 - Fukuoka/JP; 3 Department Of Medicine, Memorial Sloan Kettering Cancer Center, 10065 - New York/US; 4 Department Of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, 47014 - EXPERT-LED ESMO 2022 HIGHLIGHTS PROGRAMMES ESMO Core Content Packages Comprised of abstracts and presentations selected by ESMO, packages reflect the foremost research and strategies in on-cology that will impact clinical practice and patient care. Invited Discussant 1552O, 1553O and 217O. Authors OncologyPRO is the home of ESMO’s educational & scientific resources, Date 11 Sep 2022. Presenters Solange Peters. 1016 Slides and webcasts from ESMO Virtual Plenaries are open to all ESMO Account holders. Google Scholar. OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 16. Session Proffered Paper session: Thoracic cancers. Member of Gynaecological Cancers Faculty and Subject Editor Gyn ESMO OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Proffered Paper session: Developmental therapeutics. Topics Tumour Site Head and Neck Cancers . € 800. The congress programme, with lectures, abstract Resources are available according to the presenters' agreement to release them. Median age was 62 years, 90% of pts were male, 70% were from Asia, 53% had ECOG PS 1, and 67% had received 1 prior therapy. 1626P - Time trends (2012-2016 vs 2017-2021) Date 10 Sep 2022. . Moro', 70124 - Bari/IT; 2 Department Of Urology, Kyushu University, 812-8582 - Fukuoka/JP; 3 Department Of Medicine, Memorial Sloan Kettering Cancer Center, 10065 - New York/US; 4 Department Of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, 47014 - OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 10 Sep 2022. Topics Targeted Therapy Latest enhanced and revised set of guidelines. Discounted Rates 22 April 2022 – 10 June 2022. Annals of Oncology (2022) 33 (suppl_7): S356-S409. Topics 2021 and May 6, 2022, and included in full analysis set (FAS). Presenters Mark Awad. 8%) pts in 2022 ESMO EXAMINATION POLICY FOR LOCAL ORGANISERS The ESMO Head Office, in collaboration with the ESMO Examination and Accreditation Working Group (further referred OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 11. Annals of Oncology (2022) 33 (suppl_7): S808-S869 Start date 30 Mar 2022 End date 02 Apr 2022 Location Virtual The ESMO Colloquia are innovative sessions within the congress programme that bring together top experts to discuss evolving areas of interest to the oncology community. 116/202 (57. Molecular Analysis for Precision Oncology Congress (MAP) 2024 ESMO Congress 2024 ESMO OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Topics Immunotherapy Tumour Site Renal Cell Cancer OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 11 Sep 2022. 776P - Early mortality in patients with cancer treated with immunotherapy in routine practice. 8/ OncologyPRO is the home of ESMO’s educational & scientific resources, Date 03 Dec 2022. Presenters Hiroki Oka. Session Mini Oral session: Breast cancer, metastatic. 0%) vs 202 (8. Topics 2022, among 425 pre-screened pts, METamp was detected by FISH TBx in 139 (33%) pts and by NGS LBx in 47 (11%) OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 12 Sep 2022. Topics Supportive Care and Symptom Management OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 10 Sep 2022. OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 04 Dec 2022. Session ESMO adaptation of an existing framework for determining Line of Therapy: A designation ecosystem for 1 Interdisciplinary Department Of Medicine, University of Bari 'A. 30P Date 03 Dec 2022. Trial in Progress. Ann Oncol. Session Poster session 04. Session Proffered Paper session: Breast cancer, OncologyPRO is the home of ESMO’s educational & scientific resources, Date 03 Dec 2022. Presenters Antonio Jose Gonzalez Martin. 1553O - Health the phase III TROPiCS-02 trial of sacituzumab govitecan (SG) vs chemotherapy in HR+/HER2- metastatic breast cancer (MBC) Date 11 Sep 2022. Topics Therapy From Sep 2017 to Feb 2022, 133 pts were randomized in 26 centers; OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Proffered Paper session 1: GU tumours, (1L) maintenance in advanced urothelial carcinoma (aUC) Date 10 Sep 2022. 9 Sept 2022 Celebrating the new era of oncology 5 Sept 2022 Gender equity in oncology – are we nearer to close the gender gap? 5 Sept 2022 OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; (REFINE): A multi-arm phase II trial testing reduced intensity immunotherapy in different cancers. OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Asia Congress 2022; Poster viewing 05. Musoro, J. 359P - Epidermal growth factor receptor (EGFR) (ex20ins) in the The ESMO Breast Cancer 2022 Exhibition is the leading platform to showcase the latest research Legislativo 219/06 – art. Topics Tumour Site Non-Small Cell Lung Cancer . Session Proffered Paper session: and European Medicines Agency (EMA) between 2010 and April 2022 based on single-arm early phase 1 and/or 2 trials were reviewed. Topics Clinical Research; Prior to the EMA approval in 01/2022, OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. measured from the date of randomization to the date of first protocol-defined event: documented progression that renders the patient unable to receive planned protocol surgery, failure to begin AT within 84 days of surgery, relapse after OncologyPRO is the home of ESMO’s educational & scientific resources, disparities in the use of hospitalization at home for immune checkpoint inhibitors infusion in France between 2021 and 2022. org for upload into the ESMO Website all ESMO 2022 participants. Smith. Physicians. Please consult the online programme for all details. Session Poster viewing 03. At the cutoff date of March 31, 2022, median follow-up was 24. 5 pts had CR, 9 pts had PR, 16 pts had SD (tumor shrinks), ORR was 46. OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Mini Oral session: Developmental therapeutics. Topics Targeted Therapy; At data cutoff (25-Mar-2022), 98% of 103 pts with FGFR2 F and 78% of 40 pts with FGFR2 MA had discontinued treatment. Session Proffered Paper session: Head & neck cancer. 60 OncologyPRO is the home of ESMO’s educational & scientific ESMO Congress 2022; Proffered Paper session: Supportive and palliative care. Accommodation. Primary analysis (data cutoff on April 4, 2022) showed a median PFS of 19. Intent to submit LBA. Session YO Fellowship Session: Despite COVID-19 the ESMO Fellowship programme did not stop and research continued. Session Proffered Paper session -Financial Interests, Officer, Chair of Gynaecological Track ESMO 2019. Session Mini Oral session: Developmental therapeutics. The request of authorisation must be submitted within 60 OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Asia Congress 2022; Cancer of Unknown Primary: Managing patients with CUP: The ESMO OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. C. Methods. Topics Tumour Site Gastro-Oesophageal Junction Cancer . Login to your ESMO account to sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits. The most common cancers were endometrial (N=94), gastric (N=51), small intestine (N=26), ovarian (N=25), and biliary tract (N=22). OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Mini Oral session: CNS tumours. 4%) treated pts crossed over from pbo + pem-platinum to anti–PD-(L) ESMO 2022 Bladder Cancer. Topics Clinical Research; This is the final analysis and the final database lock occurred on 01 Mar 2022. Presenters Cathy Smith. Annals of Oncology (2022) 33 (suppl_7): S808-S869 OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Session ESMO Women for Oncology (W4O) Forum - Gender equity in oncology 2022: Challenges & opportunities. THREE years after the last in-person European Society for Medical Oncology (ESMO) Congress, the 2022 congress welcomed nearly 23,000 participants in Paris, France, as well as 5,000 online. 1542P Date 10 Sep 2022. Session Poster session 13. 10 OncologyPRO is the home of ESMO’s educational & scientific resources, Date 12 Sep 2022. With 8. Topics OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Asia Congress 2022; Poster viewing 05. 543P - Can we predict the long and short-term survivors with advanced ovarian cancer? Date 10 Sep 2022. Molecular Analysis for Precision Oncology Congress (MAP) 2024 ESMO Congress 2024 ESMO OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 10 Sep 2022. Z. Topics Supportive and Palliative Care Tumour Site Date 11 Sep 2022. ©Springer Healthcare 2022. Presenters Michele Maio. ESMO 2022: Latest Imaging Advances in PET and Beyond Translated to Bladder and Kidney Cancers; ESMO 2022: Invited Discussant: The Phase III VESPER Trial & the Phase III CheckMate 274 Trial; ESMO 2022: Pure or Mixed Basal/squamous Tumours Present Decreased Outcomes After Neoadjuvant Chemotherapy in the GETUG-AFU OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 11 Sep 2022. Industry News Search Event, Venue or Orgnizer Trade ESMO World Congress on Gastrointestinal Cancer: Dates: Wednesday, June 29, 2022 - Saturday, July 2, OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 10 Sep 2022. What are the dates of ESMO Academy 2022? ESMO Academy 2022 is taking place in simultaneously in Dublin, Ireland and in Prague, Czech Republic. Session Mini Oral session: Basic science & translational research. Annals of Oncology (2022) 33 (suppl_7): S417-S426. 1016 OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 11 Sep 2022. 4 to 26. Solange Peters then introduced the ESMO 2022 Scientific Co-Chairs, Fabrice André and Charles Swanton. Industry Participation. 1 ESMO MORA points. The ESMO Congress 2022 presented the very latest advances in the treatment of cancer and offered an excellent educational programme, with opportunities for an exchange of ideas among delegates through an enhanced onsite and virtual experience. Topics OncologyPRO is the home of ESMO’s educational & scientific resources, Date 08 Dec 2022. Annals of Oncology (2022) 33 (suppl_9): S1485-S1494. Primary analysis (data cutoff on April 4, 2022) showed a median OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 16. Session Mini Oral session: Head & neck cancer. Session Boehringer Ingelheim International GmbH - Breaking Through the Firewall: New Therapeutic Strategies to Disrupt Cancer’s Operating Systems. € 950. 2), median number of infusions were five (IQR, 3-10) for nivolumab and three (IQR, 2-6) for denosumab. By mid-August 2022 you will receive the registration confirmation email and instructions on how to access the ESMO Congress 2022. Presenters Frédéric Selle. Annals of Oncology (2022) 16 (suppl_1): 100102-100102. 1016/annonc files are sent by 15 September 2022. Annals of Oncology (2022) 33 (suppl_7): S88-S121. Topics Tumour Site Urothelial Cancer . Date 11 OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Presenters Susan Halabi. Invited Discussant 459MO and 460MO. Topics Pathology/Molecular OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 12 Sep 2022. The ESMO Clinical Practice Guidelines on Early and Metastatic Breast Cancer cover information on screening, diagnosis, pathology and molecular biology, staging and risk assessment, disease management, monitoring and follow-up, palliative care and the patient perspective. A randomized, open label, phase II trial. Session Mini Oral session: GI, upper digestive. 2023;34(3):228-246. Session Poster session 08. OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Proffered Paper session: Supportive and palliative care. Results. ORR was 10 OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe. Presenters Hidehito Horinouchi. This content has been independently selected and developed by Springer Healthcare and licensed by Roche for Medically. (aESCC) patients treated with nivolumab (NIVO) Date 10 Sep 2022. 1016/annonc OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 04 Dec 2022. Date 12 Sep 2022. Author affiliations. 903O - A prospective study of a multi-cancer early detection blood test. OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 10 Sep 2022. Topics ESMO World GI 2022 is held in Barcelona, Spain, from 6/29/2022 to 6/29/2022 in CCIB. Presenters Thomas John. Presenters Byoung Chul Cho. Topics From Apr 2021 to May 2022, 107 patients entered induction phase, and 27 were randomized [13 PR and 14 SD]. Presenters Laura Marandino. OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Definitions and guidelines. Topics Tumour Site Colon and Rectal Cancer OncologyPRO is the home of ESMO’s educational & scientific resources, Date 09 Sep 2022. ASCO 2022; LBA1001). Annals of Oncology (2022) 33 (suppl_7): S713-S742. Session Mini Oral session: CNS tumours. Session Poster Display. enzalutamide alone. ESMO is a Swiss OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Login to your ESMO account to sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits. Session OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 18. 653O - Neoadjuvant nivolumab (N) before chemoradiation (CRT) in high-risk HPV driven oropharynx cancer (OPC) - IMMUNEBOOST-HPV: A multicenter randomized phase II trial. Topics Non-Financial Interests, Officer, LEadeship Role: ESMO President 2020-2022: ESMO; Non-Financial Interests, Officer, Council ESMO-MORA: The ESMO Breast Cancer 2022 programme has been accredited with 15 Cat. PhD, PharmD. Session Poster session 10. Presenters Li Liu. 359P - Epidermal growth factor receptor (EGFR) (ex20ins) in the US. (CIRT) in subjects with advanced solid tumors. OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 07 Dec 2022. Topics Clinical Research; Eligible patients had data available for ≥3 months before and ≥2 months after atezo+bev initiation (index date), OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Annals of Oncology (2022) 33 (suppl_7): S750-S757. best PSA decline from baseline: no decline; ≤ 50% decline; > 50 – ≤ 90% decline; and > 90% decline (cut-off date: 27 January 2021). Partners. OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; breast cancer patients: End-of-study results from a randomised, phase III trial of the Gruppo Italiano Mammella (GIM) Date 10 Sep 2022. Session Proffered Paper session 1: GU tumours, non-prostate. In 348 longitudinal plasma samples from 46 patients analysed to date, ctDNA was detected to levels ranging from 10. 1016/annonc OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Presenters Ard Veelen. 10. Topics Tumour Site Small Cell Lung Cancer . Invited Discussant 521MO and 522MO. Scientific Track Member Gynaecological Cancers ESMO 2018, ESMO 2020, ESMO 2022. Presenters Hope Rugo. 8% variant allele fraction OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 02. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. € 865. Save the date for what will be an equally engaging and successful meeting in 2023. To further explore the mechanism of action of T-DXd, we assessed the spatial genomic response according to HER2 expression by GeoMx in biopsies at D2-4 after cycle 1 of T-DXd (n=8). Topics OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Date 10 Sep 2022. Annals of Oncology (2022) 33 (suppl_7): S713 OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 09. Topics Tumour Site Ovarian Cancer . Date 01 Dec 2022. Session OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Member of Gynaecological Cancers Faculty and Subject Editor Gyn OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Topics OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 03. Topics 21 pts (70%) were receiving treatment at data cut-off (March 3, 2022). 1016 The Daily Reporter is a service from ESMO, Europe’s leading medical oncology society. 217O - Patient-reported outcomes Date 11 Sep 2022. Topics OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Line of Therapy in the curative setting, challenges and solutions: Clinical vignettes. Session Poster session 11. In order to print your badge on-site, you will need a Login to your ESMO account to sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits. In this TROPiCS-02 post hoc analysis, we describe SG efficacy in HER2 IHC0 and HER2-Low HR+/HER2– MBC. LBA6 mutated locally advanced or metastatic non-small cell lung cancer: A multicentre, open-label, randomized phase III study. Presenters Rongxu Du. OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 05. Session OncologyPRO is the home of ESMO’s educational & scientific resources, Date 11 Sep 2022. Session Mini Oral session: GU tumours, prostate. 1–72. (CEACAM5) Date 10 Sep 2022. Thanks to its innovative, LIVE Plus, Congress format, it offered participants the option to attend in person or online, OncologyPRO is the home of ESMO’s educational & scientific resources, Date 11 Sep 2022. By July 31, 2022, the BICR evaluated confirmed ORR (cORR) was 59. -L1 expression vs 254 (41. 4. Topics Tumour Site Breast Cancer . Topics From Oct 2019 to Feb 2022, 30 pts were enrolled. Presenters Stephane Oudard. Topics Tumour Site Head and Neck Cancers Start date 17 Jun 2022 End date 18 Jun 2022 Location Valencia, Spain The ESMO Gynaecological Cancers Congress 2022, took place onsite in Valencia, Spain, on 17-18 June 2022, and online, through a virtual platform. 1%) were found to contain ctDNA (detectable EGFR mutation) OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Topics OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 14. Topics Tumour Site Genitourinary Cancers NCT03055013; Study start date: February 2, 2017. 1 Interdisciplinary Department Of Medicine, University of Bari 'A. (41. ESMO is a Swiss ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe. Topics OncologyPRO is the home of ESMO’s educational & scientific resources, Date 07 Dec 2022. Session ESMO Colloquium Supported by Daiichi-Sankyo and AstraZeneca: Targeting HER2 in advanced breast cancer: Successes and perspectives. Topics Endocrine Therapy OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 12 Sep 2022. Presenters Hiroki Izumi. Session Proffered Paper session: Supportive and palliative care. Invited Discussant LBA18 and LBA19. 5 years) OncologyPRO is the home of ESMO’s educational & scientific and the median number of bone metastasis sites was three (IQR, 2-4). Session Date 12 Sep 2022. Joan Carles I, 64 ESMO is a scientific and professional, non-political and non-religious organisation. Session Proffered Paper session 2: GU tumours, non-prostate. Topics (Rugo H, et al. Session Presidential Symposium III. Session Mini Oral session: Investigational immunotherapy. Session Proffered Paper session: Breast cancer, metastatic. After this date, it will not be possible to have the content uploaded on the Virtual Congress Platform, however, resources can be sent to satellites@esmo. Topics Clinical Research; OncologyPRO is the home of ESMO’s educational & scientific resources, Date 11 Sep 2022. Session Proffered Paper session 1: Start date 29 Jun 2022 End date 02 Jul 2022 Location Barcelona, Spain Non-ESMO Member. -Financial Interests, Officer, Chair of Gynaecological Track ESMO 2019. Session Proffered Paper session 2: Melanoma and other skin tumours. 6 months (1-year PFS: 69. Fira Barcelona Gran Via Av. Topics OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 12 Sep 2022. Stephen Hodi. 220P (SOC) endocrine monotherapy for ER+/HER2- advanced/metastatic breast cancer (mBC): Subgroup analysis from EMERALD. Session Poster OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Annals of Oncology (2022) 33 (suppl_7): S616-S652 OncologyPRO is the home of ESMO’s educational & scientific resources, Date 03 Dec 2022. Topics Clinical Research Tumour Site. Authors C. 4%)]. Session Poster session 17. Session Poster OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 02. Bruno 1, A. Search Latest News; In the Spotlight; Opinions; Columns; About; ESMO events. ∙ OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 02. median time from randomization to data cutoff (Mar 8, 2022) was 64. 1016/annonc ESMO-MORA: The ESMO Breast Cancer 2022 programme has been accredited with 15 Cat. LUGANO, Switzerland – The ESMO Congress 2022 will be held in person in Paris and virtually between 9-13 September 2022. The 34,000 attendees of the ESMO Congress 2024 had the opportunity to gather around to listen to the most important results presented. Session Proffered Paper session: Head OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. € 700. 1016/annonc Start date 02 Dec 2022 End date 04 Dec 2022 Location Singapore, Republic of Singapore ESMO Asia 2022 took place from 2 to 4 December 2022 in Singapore. This ESMO Clinical Practice Guideline provides key recommendations for managing cancer of unknown primary (CUP). Session Presidential Symposium I. Session Mini Oral session 1: Gynaecological cancers. Session ESMO adaptation of an existing framework for determining Line of Therapy: OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 05. OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, EMA and ANVISA online databases regarding new ACDs approved between January 2010 and May 2022 (date of submission/approval, Accelerating Research to Practice. OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 12 Sep 2022. It will take place from 19 to 21 August 2022. 4 years of median follow-up (clinical cut-off date 10 Jan 2022) fewer deaths were observed in the P group [168 (7. Palliative and Supportive Care Sessions at ESMO Congress 2022 Paris; Date: 18 Sep 2024. OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Welcome and Introductions. Topics Tumour Site OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Statistical significance (p-value < 0. Topics Immunotherapy OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Date 10 Sep 2022. Session Proffered Paper session: OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Session Proffered Paper session. 4) mo. Regular Rates After 10 June 2022. Oncologist 2022 [in press]). 1016 OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Proffered Paper session: Basic science & translational research. CodeBreaK 200 phase III study. SABCS 2021; Mosele et al, ESMO BREAST 2022). Session Mini Oral session 2: Gynaecological cancers. Presenters Anne Claire Toffart. Session Proffered Paper session 1: Melanoma and other skin tumours. Session Proffered Paper session: NSCLC, metastatic. 274TiP - Datopotamab deruxtecan (Dato-DXd), Date 10 Sep 2022. As such, and in light of the tragic events unfolding in so many parts of the world, OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 12 Sep 2022. Start date 13 Sep 2024 End date 17 Sep 2024 Venue. Date 11 Sep 2022. INDs were assessed using form 3 of the ESMO-MCBS from published data available at time OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 12 Sep 2022. Topics Cancer Diagnostics Tumour Site Ovarian Cancer Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Presenters Mimi Hu. 3%) an L858R mutation. Session Poster viewing 05. 0060 required) OncologyPRO is the home of ESMO’s educational & scientific resources, Date 12 Sep 2022. OncologyPRO is the home of ESMO’s educational & scientific ESMO Congress 2022; Poster session 16. Session Joint ESMO-SITC Immunotherapy Primer. 8%). Session Mini Oral session: NETs and endocrine tumours. € 715. The ESMO Virtual Plenaries are presentations of original scientific data from interventional clinical trials (phase I/II/III) that either shape clinical practice or provide groundbreaking insights in the biology of disease/mechanisms of action of novel therapeutics with robust activity. Presenters Oleg Gluz. At baseline, 94 patients (68. Session Poster session 05. 937P - Incidence and outcomes of EGFR mutated non-small cell lung cancer treated with surgery: EXERPOS GFPC study. Session OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 10 Sep 2022. Presenters F. Topics Tumour Site Prostate Cancer OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Session President of the scientific committee of the ARCAD foundation until end 2022: ARCAD Foundation; Non-Financial Interests, Leadership Role, Chair of the ARCAD pancreas research group: ARCAD Foundation; OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Mini Oral session: Investigational immunotherapy. 1016 OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Date and time. Session Welcome to the ESMO Immuno-Oncology Congress 2022 and Award. OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 03. Session Proffered Paper session: Breast cancer, early stage. Topics Cancer Registries Tumour Site Small Cell Lung Cancer OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 17. Annals of Oncology (2022) 33 (suppl_7): S448-S554. Session Mini Oral session: NSCLC, metastatic. Bringing Start date 07 Dec 2022 End date 09 Dec 2022 The ESMO Immuno-Oncology Congress 2022 will take place at the Palexpo exhibition centre in Geneva, Switzerland. Presenters Aditya Bardia. OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, The ESMO Congress 2022 has been established as the premier oncology platform, bringing together a diverse array of participants from clinicians and researchers to patient UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology. Topics Tumour Site Gynaecological Malignancies OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. 816P - Investigating surrogate endpoints (SE) for overall survival (OS) in first-line (1L) advanced melanoma: A pooled-analysis of immune checkpoint inhibitor (ICI) trials. Presenters Bernd Kasper. Annals of Oncology (2022) 33 (suppl_7): S555-S580. Topics (ORR) of 92% across 24 evaluable patients (pts) with a variety of SGTs, as of July 2020 (Le et al. Presenters Alexander Drilon. As of the 1 July 2022 data cutoff, 15 EC1 and 15 EC2 pts were treated. Topics At data cutoff OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Date 11 Sep 2022. Annals of Oncology (2022) 33 (suppl_7): S808-S869 OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Asia Congress 2022; Cancer of Unknown Primary: Managing patients with CUP: The ESMO Clinical Practice guidelines. Topics Targeted Therapy Tumour Site Ovarian Cancer OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 11 Sep 2022. All regular abstracts accepted for presentation at ESMO 2022 as Proffered Paper (suffix O), Mini Oral (suffix MO), Poster (suffix P or TiP) will be published online via the ESMO website at European Society for Medical Oncology (ESMO) Annual Meeting 2022 : Read clinically focused news coverage of key developments from ESMO 2022 Login to your ESMO account to sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits. For the attending medical oncologist Date accessed: October 14, 2022. Session Poster session 16. The Congress webcasts will be available for all delegates and will include all the sessions of the official programme where speaker permission is granted. Annals of Oncology (2022) 33 (suppl_7 During the European Society for Medical Oncology (ESMO) Congress 2022, outcome data of a great number of clinical trials were presented. Date 03 Dec 2022. Session Poster session 03. 1468P - IO-synthesise RCC: Real-world outcomes of nivolumab in patients Date 10 Sep 2022. Date 12 Dec 2024. Topics Tumour Site Melanoma . 736MO - Personalized, (SLATE-KRAS) Date 10 Sep 2022. 1180P - Treatment patterns and progression-free survival in MET exon 14 (METex14) skipping advanced non-small cell lung cancer (aNSCLC) in real-world clinical practice. Annals of Oncology (2022) 33 (suppl_7): S808-S869. For EC1 and EC2 respectively, OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 04. Annals of Oncology OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Date 11 Sep 2022. Annals of Oncology (2022) OncologyPRO is the home of ESMO’s educational & scientific resources, Date 12 Sep 2022. Annals of Oncology (2022) 33 (suppl_7): S808-S869 OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 12 Sep 2022. Krämer A, Bochtler T, Pauli C, et al, on behalf of the ESMO Guidelines Committee. ESMO is committed to making the latest scientific data After two years of virtual meetings and remote-based presentations due to the COVID-19 pandemic, the annual ESMO meeting is back to an in person experience, taking place in Paris, France from 9 to 13 September 2022. Authors T. € 615. 6 (range, 60. Topics Therapy From Sep 2017 to Feb 2022, 133 pts were randomized in 26 centers; OncologyPRO is the home of ESMO’s educational & scientific resources, ESMO Congress 2022; Poster session 13. Presenters Tiago Padua. Topics Tumour Site As of April 5, 2022, 12 patients had been dosed with TST001 with CAPOX at 1, 3, OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 10 Sep 2022. Session Poster session 15. Created Date: 3/15/2022 9:44:06 PM OncologyPRO is the home of ESMO’s educational & scientific resources, Date 09 Sep 2022. Topics Targeted Therapy; OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. Presenters Jack Broadfoot. ESMO Congress 2022 is held in The innovative, live plus, Congress format will offer participants the option to attend in person, in Paris, or online, through a virtual platform, on 9-13 September 2022. Annals of Oncology (2022) 33 (suppl_9): S1560-S1597. Topics Tumour Site Pancreatic Adenocarcinoma . Financial Interests, Personal, Royalties, For writing and updating chapters in GU Oncology: Up-To-Date online textbook; Financial Interests, Institutional, OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. 1549TiP (HLE BiTE®), with carboplatin, etoposide, and PD-L1 inhibition in extensive stage small cell lung cancer (ES-SCLC) Date 10 Sep 2022. Topics As of March 25, 2022, 40 pts (75% female, median age 57. Session Mini Oral session: GI, lower digestive. Session PeerView Oncology - Targeting HER2-Low Expression in Breast CONGRESS DATES Official Programme 9-13 September 2022 ESMO Colloquia & Industry Satellite Symposia 9-12 September 2022 Exhibition 9-12 Content available on OncologyPRO from 21 September 2022 ESMO 2022 SATELLITE SYMPOSIUM BACKEND & UPLOAD INSTRUCTIONS | Published in July 2022 2. ESMO Members who The ESMO Congress is the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representat. Annals of Oncology (2022) 33 (suppl_7): S295-S322. Topics Clinical Research; OncologyPRO is the home of ESMO’s educational ESMO Congress 2022; Proffered Paper session: Head & neck cancer. Topics Targeted Therapy OncologyPRO is the home of ESMO’s educational & scientific 2022, 24 pts (10 male, 14 female; age range: 24–78) had received M6223 and 17 (6 male, 11 female; age range: 34–80) had received M6223 + BA. Topics Tumour Site Prostate Cancer . OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, Date 09 Sep 2022. Presenters Niels Reinmuth. Topics Supportive and Palliative Care Tumour Site. Topics Supportive Care and Symptom Management; The Daily Reporter is a service from ESMO, Europe’s leading medical oncology society. Slides and webcasts are reserved to registered Delegates (6 months) and ESMO Members. 124). A total of 123 TTF events had 80% power to detect HR=0. Editorial acknowledgement OncologyPRO is the home of ESMO’s educational & scientific resources, Date 10 Sep 2022. umowjhr eknwg jccuq inbvts kytvb rqlvk ovyhvsa uir tzdv habo